No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D05
- Name in latin
- Carcinoma in situ lobulare mammae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, lobular
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of breast, lobular
- In situ neoplasms
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1248 | 1248 | - |
| Only index persons | 1180 | 1180 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | - |
| Only index persons | 0.04 | 0.04 | - |
| Median age at first event (years) | |||
| Whole population | - | 58.52 | - |
| Only index persons | - | 58.36 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 244 | 244 | - |
| Unadjusted period prevalence (%) | 0.08 | 0.08 | - |
| Median age at first event (years) | 58.32 | 58.32 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 214
- Matched controls
- 2140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
306.6
213
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
2633.6
138.5
119
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
131.1
112
*
115
Kela drug reimbursment
Breast cancer
+∞
103.8
91
*
HAC20
NOMESCO Finland
Total mastectomy
1048.4
77.4
71
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
129.6
73.9
76
9
HA1AA
NOMESCO Finland
X-ray mammography
39.4
72.0
92
40
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
70.8
64
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
42.4
67.3
84
32
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
62.6
57
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
53.4
49
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
50.0
46
*
HAB99
NOMESCO Finland
Other partial excision of mammary gland
89.5
49.9
54
8
L02BA01
ATC
tamoxifen; oral
+∞
48.8
45
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
48.8
45
*
L02BG04
ATC
letrozole; oral
110.7
48.3
51
6
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
204.9
48.0
48
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
44.3
41
*
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
+∞
43.2
40
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
+∞
43.2
40
*
H02AB02
ATC
dexamethasone; systemic
57.1
42.2
49
11
TQW20
NOMESCO Finland
Tatoe
+∞
36.5
34
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
36.5
34
*
A04AA02
ATC
granisetron; systemic, transdermal
410.9
36.1
35
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
35.4
33
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
34.3
32
*
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
+∞
34.3
32
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
392.0
33.9
33
*
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
32.1
30
*
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
+∞
31.0
29
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
80.3
30.9
34
5
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
29.9
28
*
N63
ICD-10 Finland
Unspecified lump in breast
12.1
29.3
56
61
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
28.8
27
*
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
321.2
28.5
28
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
27.7
26
*
XX3DW
NOMESCO Finland
Time consuming IT work
14.4
27.7
48
42
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
22.8
26.4
38
20
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
24.4
23
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
24.4
23
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
37.0
23.1
29
9
L03AA13
ATC
pegfilgrastim; parenteral
+∞
22.3
21
*
X76
ICPC
Malignant neoplasm breast female
+∞
22.3
21
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
+∞
22.3
21
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
21.2
20
*
ZZR10
NOMESCO Finland
Flap of skin and muscle
+∞
21.2
20
*
HAE99
NOMESCO Finland
Other reconstruction of breast
231.6
21.0
21
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.2
20.3
100
366
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
18.0
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
18.0
86
300
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
20.9
17.8
26
14
A03FA01
ATC
metoclopramide; systemic, rectal
4.8
17.3
65
178
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
38.5
17.0
21
6
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
+∞
16.9
16
*
L02BG03
ATC
anastrozole; oral
+∞
16.9
16
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
97.8
16.8
18
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
183.7
16.7
17
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
4.0
15.8
74
248
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
8.8
14.8
32
42
A04AA55
ATC
palonosetron, combinations; systemic
+∞
14.8
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.8
14
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
+∞
14.8
14
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
14.8
14
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
14.8
14
*
ZXE10
NOMESCO Finland
More than one and less than three hours
3.2
14.6
109
521
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
57.3
14.0
16
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
13.7
13
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
13.7
13
*
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
13.7
13
*
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
13.7
13
*
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
+∞
13.7
13
*
Z31.5
ICD-10 Finland
Genetic counselling
10.8
13.7
26
27
TQB05
NOMESCO Finland
Puncture of skin of trunk
74.4
12.7
14
*
D24
ICD-10 Finland
Benign neoplasm of breast
14.4
12.7
21
16
L02BG06
ATC
exemestane; oral
+∞
12.6
12
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
12.6
12
*
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
137.7
12.6
13
*
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
68.8
11.7
13
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
11.6
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
45.8
11.0
13
*
HAD99
NOMESCO Finland
Other plastic operation on breast
115.4
10.5
11
*
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
+∞
10.5
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
10.5
10
*
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
+∞
10.5
10
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
9.2
10.3
21
25
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
10.2
110
617
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
57.7
9.7
11
*
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
18.6
9.5
14
8
WX402
NOMESCO Finland
General anaesthesia
3.6
9.5
45
147
ZSH00
NOMESCO Finland
Procedure related to previous procedure classified in chapter H
+∞
9.4
9
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
9.4
9
*
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
+∞
9.4
9
*
130
Kela drug reimbursment
Malignant tumour
+∞
9.4
9
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
+∞
9.4
9
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
6.3
9.2
24
42
ZXE30
NOMESCO Finland
More than five and less than seven hours
7.4
9.1
21
31
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.4
9.1
27
56
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
+∞
8.4
8
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
8.4
8
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
8.4
8
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
+∞
8.4
8
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C50.89
ICD-10 Finland
Overall malignant tumor of the mammary gland, other or undeterminated histology
+∞
8.4
8
*
X21
ICPC
Breast sympt/compl female other
15.3
8.3
13
9
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
34.8
8.1
10
*
JN4BD
NOMESCO Finland
Extensive body CT
5.6
7.8
22
43
ZXE20
NOMESCO Finland
More than three and less than five hours
3.4
7.8
39
133
A04AA01
ATC
ondansetron; systemic, rectal
8.5
7.7
16
20
B01AB05
ATC
enoxaparin; parenteral
2.4
7.7
77
400
WZC30
NOMESCO Finland
Teaching
3.8
7.7
33
99
ZXA05
NOMESCO Finland
Left side
2.5
7.6
71
355
WF002
NOMESCO Finland
Radical radiotherapy
82.8
7.5
8
*
JN4AD
NOMESCO Finland
Body CT examination
8.9
7.5
15
18
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
7.3
7
*
HAD50
NOMESCO Finland
Removal of prosthetic implant from breast
31.2
7.2
9
*
HA4ST
NOMESCO Finland
Labeling mammary gland pathology with sterotactic guidance
41.4
6.8
8
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
6.6
97
597
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
9.7
6.4
12
13
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
6.3
6
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
6.3
6
*
C50.80
ICD-10 Finland
Overall malignant tumor of the mammary gland, no histological veryfication
+∞
6.3
6
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
6.3
6
*
HAC25
NOMESCO Finland
Radical mastectomy
+∞
6.3
6
*
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
+∞
6.3
6
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
6.3
6
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
6.3
6
*
C50.10
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, no histological veryfication
+∞
6.3
6
*
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
6.3
6
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
6.3
6
*
9703
FHL
Breast resection
27.6
6.3
8
*
Z3231
NOMESCO Finland
Registered nurse
2.2
6.1
69
374
ZXA00
NOMESCO Finland
Right side
2.2
6.0
71
393
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
58
61
12.16
51.63
1.7
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
42
30
16.70
47.08
1.5
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
62
150
5.20
25.12
1.4
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
49
103
5.70
23.15
4.4
1.3
ug/l
5.0
2.8
1.52
38
81
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
161
1001
2.79
12.98
8.0
3.3
umol/l
8.9
10.2
3.01
153
928
(40768804) Tissue Pathology biopsy report
131
750
2.61
12.25
2.9
1.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
101
517
2.63
11.80
2.3
1.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
156
1098
2.17
7.63
9.6
6.3
e9/l
3.6
4.0
2.45
136
946
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
129
857
2.07
7.21
4.0
3.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
201
1598
2.46
6.88
9.6
5.3
u/l
82.4
76.0
0.70
194
1448
(3015377) Calcium [Moles/volume] in Serum or Plasma
110
727
1.93
5.89
4.1
2.0
mmol/l
2.4
2.4
2.26
99
590
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
411
1.99
5.19
2.3
1.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
140
1030
1.84
5.14
7.6
4.8
mmol/l
1.2
1.2
0.62
120
875
(40758558) Short blood count panel - Blood
73
474
1.77
3.83
7.2
4.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
64
414
1.74
3.36
3.3
3.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
111
843
1.58
3.07
4.3
3.4
g/l
36.5
36.1
0.41
100
771
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
16
64
2.61
2.94
2.3
1.6
iu/l
4.3
5.6
—
6
22
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
120
936
1.56
2.91
5.7
4.4
mmol/l
1.2
1.2
0.52
113
820
(3032080) INR in Blood by Coagulation assay
102
768
1.56
2.88
5.9
7.9
inr
1.1
1.2
1.60
28
238
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
32
3.22
2.68
1.1
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
188
1656
1.59
2.40
3.9
4.6
mm/h
13.0
12.8
0.07
170
1502
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
13
4.70
2.28
8.3
1.7
nmol/l
9.4
3.6
—
6
13
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
82
624
1.47
2.08
3.8
2.5
u/l
34.1
28.3
0.44
75
595
(3033658) Prothrombin time (PT) actual/Normal
63
454
1.52
2.08
4.1
2.9
%
102.5
94.2
2.04
63
437
(3020564) Creatinine [Moles/volume] in Serum or Plasma
237
2269
2.55
2.00
19.5
13.2
umol/l
70.2
70.1
0.02
237
2269
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
513
0.61
1.95
1.4
1.3
u/ml
0.5
3.0
—
6
143
(3044889) 12 lead EKG panel
176
1557
1.47
1.93
3.6
3.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
111
905
1.42
1.92
9.5
8.1
e9/l
0.0
0.0
0.60
90
733
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
28
169
1.74
1.87
3.5
2.3
mmol/l
1.2
1.2
0.05
28
138
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
224
2099
1.82
1.81
14.9
11.4
mg/l
24.4
19.3
1.10
181
1586
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
47
0.00
1.72
0.0
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
13
3.90
1.72
6.2
2.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
43
297
1.54
1.71
3.3
2.7
e6/l
2.9
4.9
0.87
21
145
(42870588) Differential panel, method unspecified - Blood
81
639
1.40
1.65
4.3
5.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
79
621
1.40
1.64
5.0
2.8
ph
7.4
7.4
0.49
17
107
(3042936) Bacteria identified in Isolate by Culture
36
242
1.57
1.62
1.8
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
26
2.74
1.59
2.1
1.9
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
11
51
2.21
1.53
1.1
2.0
%
95.7
95.1
0.02
11
45
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
109
1.81
1.51
1.2
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
464
1.42
1.51
1.5
1.6
mg/l
2.0
0.9
0.49
54
353
(3002030) Lymphocytes/100 leukocytes in Blood
113
952
1.35
1.50
5.0
5.8
%
28.9
29.3
0.14
108
864
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
18
103
1.81
1.45
1.2
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
128
1.70
1.38
1.5
1.5
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
116
991
1.33
1.37
2.5
2.3
nmol/l
85.0
81.1
0.70
107
866
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
38
0.00
1.35
0.0
2.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
39
0.00
1.35
0.0
1.2
—
21.0
—
0
34
(3049717) Cytology report of Urine Cyto stain
10
48
2.13
1.29
1.5
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
53
411
1.37
1.17
3.6
3.8
ng/l
89.2
137.4
0.41
37
316
(3009542) Hematocrit [Volume Fraction] of Blood
201
1882
1.39
1.14
17.0
12.7
%
37.7
39.5
1.55
144
1267
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
44
333
1.39
1.13
2.7
2.4
e6/l
1.2
1.4
0.17
22
180
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
54
424
1.35
1.11
2.8
2.1
mmol/l
2.5
2.4
1.52
48
361
(3030467) Casts [#/volume] in Urine by Automated count
65
525
1.32
1.11
3.3
2.9
e6/l
0.3
0.5
0.40
44
393
(3000492) Spirometry study
25
170
1.52
1.10
1.8
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
56
443
1.34
1.10
1.1
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
82
686
1.29
1.08
4.7
3.7
e6/l
111.8
101.3
0.06
53
475
(3002582) Erythrocytes [#/volume] in Urine
69
564
1.31
1.08
3.6
3.0
e6/l
20.4
25.2
0.28
49
437
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
60
481
1.33
1.07
1.4
1.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
40
518
0.73
1.04
2.7
2.1
umol/l
332.0
6071.6
2.29
35
423
(3019309) Folate [Moles/volume] in Red Blood Cells
31
419
0.70
1.04
2.0
1.7
nmol/l
1066.4
1235.1
0.57
24
293
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
28
198
1.47
1.03
2.5
2.9
—
—
—
0
0
(3003338) MCHC [Mass/volume]
189
1762
1.32
1.03
19.7
15.5
g/l
329.5
330.3
0.71
189
1751
(3036481) Cortisol [Moles/volume] in Serum or Plasma
12
199
0.58
1.02
2.4
2.1
nmol/l
316.0
351.9
0.24
12
186
(3022217) INR in Platelet poor plasma by Coagulation assay
33
242
1.42
1.01
16.7
18.8
inr
1.3
1.2
—
8
40
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
9
48
1.91
1.01
1.0
1.7
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
36
1.97
0.98
3.1
1.7
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
0
31
0.00
0.97
0.0
2.1
—
56.6
—
0
31
(3019198) Lymphocytes [#/volume] in Blood
116
1028
1.24
0.93
4.8
5.5
e9/l
1.9
1.9
0.10
99
895
(4306422)
6
28
2.17
0.92
1.0
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
101
0.48
0.91
1.0
1.0
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
131
1178
1.24
0.91
3.5
3.6
mmol/l
6.5
6.6
0.30
124
1089
(3000850) Epithelial cells [#/volume] in Urine
51
410
1.31
0.90
2.3
2.4
e6/l
5.1
7.5
1.20
39
360
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
82
947
0.80
0.90
2.0
2.0
pmol/l
100.4
99.0
0.09
36
412
(3006315) Basophils [#/volume] in Blood
114
1012
1.24
0.89
4.9
5.5
e9/l
0.0
0.0
1.79
94
860
(36304419) Bacteria [Presence] in Urine
63
523
1.28
0.87
3.2
2.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
113
1005
1.23
0.86
4.8
5.5
e9/l
0.6
0.6
0.02
94
856
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
215
2059
1.37
0.83
16.8
10.4
ml/min/173m2
77.1
77.1
0.00
183
1638
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
132
1.48
0.78
1.2
1.4
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
77
663
1.24
0.78
2.7
2.0
u/l
54.7
54.8
0.01
68
597
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
25
185
1.39
0.75
2.4
1.9
u/l
27.6
32.3
0.53
19
150
(4010399)
12
183
0.64
0.75
1.2
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
44
356
1.29
0.75
3.2
2.5
mosm/kgh2o
485.8
515.0
0.46
29
302
(3013512) EKG study
77
666
1.23
0.75
4.0
3.6
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
79
686
1.22
0.74
3.4
3.1
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
72
622
1.22
0.71
2.6
2.7
ng/l
683.0
992.8
0.79
62
510
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
118
0.58
0.70
1.1
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
11
69
1.62
0.69
4.9
1.4
g/l
1.5
0.3
0.45
11
62
(36660697) Celiac disease serology panel - Serum
12
178
0.66
0.67
1.4
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
173
1823
0.82
0.66
5.4
4.4
pmol/l
15.1
14.8
0.60
159
1657
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
25
191
1.34
0.64
4.6
1.9
umol/l
6.9
5.4
0.37
20
159
(3009343) pH of Capillary blood
6
102
0.58
0.63
1.5
3.3
—
7.4
—
0
17
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
6
103
0.57
0.63
1.8
3.3
kpa
4.7
5.2
—
6
97
(3052851) Hemolysis interference index of Serum or Plasma
8
50
1.62
0.62
7.5
2.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
115
1050
1.18
0.61
4.9
5.7
e9/l
0.2
0.2
0.55
98
914
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
51
1.59
0.61
3.0
1.8
u/ml
16.3
132.8
—
8
43
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
386.4
—
0
15
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.0
—
547.5
—
0
15
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.0
—
60.1
—
0
15
(44813793)
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
53
451
1.22
0.60
2.8
4.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
21
0.00
0.60
0.0
3.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
0
21
0.00
0.60
0.0
1.4
—
6.6
—
0
16
(3016502) Oxygen saturation in Arterial blood
22
167
1.35
0.59
3.1
5.8
%
97.0
95.9
0.93
22
162
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
12
81
1.51
0.58
5.8
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
30
241
1.28
0.56
1.7
1.3
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
11
74
1.51
0.54
3.5
5.4
mmol/l
24.3
24.9
0.35
11
67
(21494755) Public health laboratory ask at order entry panel
9
132
0.67
0.53
1.2
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
39
459
0.82
0.50
1.3
1.3
u/ml
8.9
14.2
0.38
17
173
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
13
93
1.42
0.49
4.1
4.6
mmol/l
25.9
25.9
0.02
13
93
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
24
193
1.27
0.45
3.8
4.4
mmol/l
104.3
103.8
0.21
24
187
(1761482) Bacteria [#/volume] in Urine by Culture
7
50
1.41
0.45
6.3
2.9
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
10
69
1.47
0.45
5.3
1.3
g/l
39.4
38.5
—
10
62
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
10
69
1.47
0.45
1.8
1.8
ug/l
932.6
218.8
—
10
62
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
31
1.63
0.43
1.0
1.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
6
92
0.64
0.43
1.2
1.3
—
25.4
—
0
6
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
32
1.57
0.42
1.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
50
566
0.85
0.42
2.8
4.3
estimate
0.0
0.0
0.00
15
186
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
26
313
0.81
0.42
6.2
6.3
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
48.9
—
0
10
(3011648) Oxygen content in Venous blood
0
15
0.00
0.41
0.0
1.8
—
9.5
—
0
15
(3023511) Choriogonadotropin [Units/volume] in Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
10.8
—
0
10
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
16
0.00
0.41
0.0
1.4
—
2.2
—
0
10
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
0.1
—
0
6
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.2
—
2.0
—
0
17
(4027681)
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
17
0.00
0.41
0.0
1.6
—
390574.0
—
0
11
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
139
1315
1.13
0.40
4.1
2.8
u/l
57.8
43.0
0.60
122
1195
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
34
1.48
0.40
1.2
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
44
501
0.85
0.40
2.3
2.2
mg/l
2.5
3.2
1.73
36
413
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
14
106
1.34
0.40
2.5
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
31
263
1.20
0.38
2.5
1.6
s
27.7
29.4
1.75
31
252
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
37
1.36
0.37
1.2
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
37
1.36
0.37
1.0
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
1.6
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
81
1.37
0.37
5.5
1.4
g/l
11.8
11.3
0.06
11
71
(3019225) pH of Specimen
27
227
1.21
0.36
7.0
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
340
1.18
0.36
1.6
1.4
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
6
41
1.47
0.36
4.0
2.1
mmol/l
1.4
1.5
—
6
41
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
13
99
1.33
0.36
3.2
5.9
%
0.9
0.7
0.98
13
99
(40761535) Cells panel - Urine sediment
14
178
0.77
0.36
2.4
3.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
44
1.37
0.34
1.0
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
88
0.67
0.33
1.2
1.3
—
4.3
—
0
19
(40761511) CBC panel - Blood by Automated count
225
2210
1.23
0.33
14.7
11.0
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
68
740
0.89
0.33
3.8
3.7
mg/mmol
5.3
5.3
0.00
46
408
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
13
101
1.30
0.32
3.2
5.9
%
1.2
1.4
0.39
13
101
(3026008) Bacteria identified in Urine by Culture
68
738
0.89
0.31
3.6
3.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
10
131
0.75
0.31
3.0
2.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
50
550
0.89
0.29
1.6
1.5
nmol/l
23.7
23.2
0.10
42
459
(3009261) Glucose [Presence] in Urine by Test strip
113
1072
1.10
0.29
3.0
3.8
estimate
0.0
0.0
0.00
14
179
(1761868) Lipid panel - Serum or Plasma
80
746
1.11
0.28
3.4
3.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
5
71
0.70
0.26
1.2
1.2
—
60.0
—
0
8
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
72
671
1.10
0.26
1.6
1.6
mmol/l
1.3
1.4
0.18
52
561
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
16
191
0.83
0.25
4.1
2.0
ml/min/173m2
67.3
66.8
—
6
76
(3007164) IgA [Mass/volume] in Serum or Plasma
38
421
0.88
0.25
1.2
1.3
g/l
2.1
2.5
0.71
17
234
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
76
1.19
0.25
4.6
7.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
126
0.78
0.25
1.5
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
83
0.72
0.24
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
6
83
0.72
0.24
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
85
0.70
0.24
1.3
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
85
0.70
0.24
1.2
1.3
—
2.1
—
0
13
(3038515) Glucose [Moles/volume] in Venous blood
5
38
1.32
0.23
4.6
2.2
mmol/l
6.2
7.4
—
5
38
(3030981) Hyaline casts [#/volume] in Urine by Automated count
12
97
1.25
0.23
3.6
2.6
e6/l
0.2
0.3
0.38
12
92
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
28
315
0.87
0.23
5.1
4.9
%
32.7
33.6
0.22
19
187
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
43
470
0.90
0.23
1.8
1.7
pmol/l
162857580.9
473.3
0.49
35
368
(40760888) Immunoglobulin light chains.free panel - Serum
5
41
1.22
0.22
8.6
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
206
2095
0.89
0.22
5.9
5.9
mmol/mol
39.7
39.6
0.09
190
1926
(3017181) Myelocytes/100 leukocytes in Blood
18
154
1.18
0.22
3.9
4.2
%
0.7
0.5
—
7
25
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
218
2210
0.87
0.21
4.8
4.8
mmol/l
5.9
5.9
0.01
198
2000
(3001019) Free T4 and TSH panel - Serum or Plasma
8
104
0.76
0.21
2.6
1.8
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
11
0.00
0.21
0.0
1.9
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.6
—
31.2
—
0
6
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.6
—
119.9
—
0
10
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
9.8
—
0
10
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
22.0
—
0
5
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
186.5
—
0
12
(3035350) Ketones [Presence] in Urine by Test strip
110
1054
1.08
0.21
3.0
3.9
estimate
0.0
0.0
0.00
14
183
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
223
2257
0.86
0.21
5.2
5.4
mmol/l
2.8
2.8
0.15
206
2063
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
111
1065
1.08
0.20
4.6
5.1
estimate
0.0
0.0
0.00
14
177
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
48
1.26
0.20
1.2
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
20
174
1.16
0.20
1.6
1.2
iu/ml
183.1
111.1
—
9
70
(3042631) Mycobacterium sp identified in Specimen
0
14
0.00
0.20
0.0
3.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
32
352
0.90
0.19
1.4
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
59
553
1.09
0.19
2.8
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
204
1.14
0.19
1.7
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
46
495
0.91
0.18
2.5
4.4
kg/l
1.0
1.0
—
9
71
(3012516) Albumin [Mass/volume] in Urine
67
708
0.93
0.18
2.9
3.0
mg/l
14.5
230.8
0.87
45
395
(3037467) Urinalysis macro (dipstick) panel - Urine
150
1460
1.07
0.18
4.4
4.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
68
0.73
0.17
1.2
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
5
70
0.71
0.17
1.2
1.9
g/l
2.0
1.6
—
5
63
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
283
1.11
0.17
1.9
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
8
69
1.16
0.16
1.4
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
70
1.15
0.16
1.5
1.7
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
43
461
0.92
0.16
1.2
1.4
iu/ml
30.2
37.3
0.21
15
153
(3021440) Promyelocytes/100 leukocytes in Blood
17
149
1.15
0.16
4.0
4.3
%
0.0
0.0
—
6
24
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
78
815
0.94
0.15
3.2
3.4
ng/l
26.7
69.9
0.47
51
554
(3019832) Treponema pallidum Ab [Presence] in Serum
7
87
0.80
0.15
1.1
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
122
1.16
0.14
1.2
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
11
128
0.85
0.14
3.1
2.2
kpa
3.9
4.3
0.48
11
123
(3045414) Leukocytes [Presence] in Urine
9
106
0.84
0.13
1.6
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
123
1.15
0.13
3.0
5.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
168
0.89
0.12
1.2
1.3
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
31
330
0.93
0.10
1.2
1.4
titre
510.0
712.2
—
8
82
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
218
2198
0.92
0.10
4.6
4.8
mmol/l
1.6
1.6
0.45
199
2014
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
79
815
0.95
0.10
2.9
4.0
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
15
165
0.90
0.09
3.2
3.6
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
21
226
0.92
0.08
2.2
2.3
%
22.7
22.4
0.02
16
183
(3014051) Protein [Presence] in Urine by Test strip
5
61
0.82
0.08
2.0
1.9
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
60
0.83
0.08
4.4
6.3
mmol/l
1.0
1.0
—
5
55
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
88
1.14
0.08
1.9
1.6
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
7
68
1.03
0.08
2.3
1.5
ug/l
0.3
1.5
—
7
61
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
6
71
0.84
0.07
1.2
1.2
—
13.4
—
0
7
(3005322) IgE [Units/volume] in Serum or Plasma
15
137
1.10
0.07
1.1
1.2
u/ml
60.5
153.9
2.05
15
126
(3001122) Ferritin [Mass/volume] in Serum or Plasma
90
921
0.96
0.07
2.4
2.7
ug/l
137.3
91.4
0.82
81
832
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
120
1179
1.04
0.07
2.7
2.6
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
81
0.86
0.07
1.4
1.5
g/l
1.3
1.2
—
7
76
(3025159) Blasts/100 leukocytes in Blood
16
148
1.09
0.06
4.0
4.3
%
0.0
0.0
—
5
24
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
210
2114
0.95
0.06
4.1
4.3
mmol/l
1.3
1.3
0.19
191
1914
(3019060) Gas panel - Arterial blood
12
110
1.10
0.05
2.6
5.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
12
110
1.10
0.05
1.4
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
10
91
1.10
0.04
1.5
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
19
180
1.06
0.04
1.6
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
71
723
0.97
0.04
2.8
2.9
mmol/l
6.2
6.4
0.26
59
596
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
209
2100
0.97
0.03
6.0
5.4
mu/l
1.8
2.5
0.62
194
1911
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
178
0.95
0.02
1.9
1.7
—
—
—
0
0
(3012544) pH of Venous blood
16
167
0.96
0.01
3.0
3.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
11
104
1.06
0.01
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
164
1.04
0.00
1.6
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
22
214
1.03
0.00
1.7
1.6
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
53
524
1.01
0.00
3.0
3.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
20
202
0.99
0.00
2.0
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
26
258
1.01
0.00
1.7
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
101
0.99
0.00
1.3
1.7
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
14
139
1.01
0.00
2.9
3.9
mmol/l
1.5
1.3
0.14
14
133
(3015736) pH of Urine
83
832
1.00
0.00
3.0
3.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
27
267
1.01
0.00
1.5
2.0
ug/g
96.3
123.4
0.35
18
210
(3000330) Specific gravity of Urine by Test strip
12
117
1.03
0.00
4.2
2.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
221
2213
0.99
0.00
4.7
4.8
mmol/l
4.9
4.9
0.37
205
2037
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
20
204
0.98
0.00
2.0
1.8
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
17
165
1.03
0.00
4.1
1.5
g/l
67.6
68.2
0.09
17
149
(46235355) HIV 1 and 2 tests - Meaningful Use set
18
185
0.97
0.00
1.6
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
14
145
0.96
0.00
2.4
2.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
12
115
1.05
0.00
4.3
7.7
mmol/l
26.2
25.4
0.32
12
109
(3021879) Hepatitis B virus core Ab [Presence] in Serum
11
105
1.05
0.00
1.5
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(4094501)
7
70
1.00
0.00
1.0
1.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
7
73
0.96
0.00
1.7
3.4
mmol/l
24.6
25.0
—
7
62
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
5
52
0.96
0.00
9.6
1.4
—
1.0
—
0
6
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
22.5
—
748.2
—
0
6
(4198724)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
6.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
8
85
0.94
0.00
1.4
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
295.5
—
0
5
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
120
1.00
0.00
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
60
1.00
0.00
1.2
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(4034850)
7
79
0.88
0.00
5.9
7.5
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
26.0
—
1583.0
—
0
6
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(44806420)
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
15
150
1.00
0.00
4.7
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
2.1
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint CD2_INSITU_BREAST_LOBULAR_EXALLC and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_INSITU_BREAST_LOBULAR_EXALLC | 1.277 [1.05, 1.55] | 0.013 |
| Birth year | 0.998 [0.99, 1.01] | 0.56 |
During the follow-up period (1.1.1998 — 31.12.2019), 162 out of 1098 females with CD2_INSITU_BREAST_LOBULAR_EXALLC died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have CD2_INSITU_BREAST_LOBULAR_EXALLC.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.128% | No data |
| 5 | 0.737% | No data |
| 10 | 2.168% | No data |
| 15 | 4.014% | No data |
| 20 | 7.071% | No data |
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_LOBULAR_EXALLC – Carcinoma in situ of breast, lobular
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data